Armin Schmitt

Title: Innovations by Inventor Armin Schmitt

Introduction

Armin Schmitt, a notable inventor based in Berlin, Germany, has made significant contributions to the field of molecular biology through his innovative methods and inventions. With three patents to his name, Schmitt's work focuses primarily on the quantification of methylation in nucleic acids and its implications in cancer treatment.

Latest Patents

One of Schmitt's latest inventions is a "Method for quantitative determination of the degree of methylation of cytosines in CpG positions." This invention elaborates on a method for quantitatively sequencing nucleic acids that have been treated with bisulfite, specifically targeting the determination of methylation levels of cytosines located at CpG positions in known genomic sequences. Significantly, this invention enhances the validation of sequence information in bisulfite-treated DNA sequencing, offering a standardized approach to data interpretation.

Another significant patent involves a "Method for determining risk of relapse of breast cancer following tamoxifen adjuvant therapy." This invention includes modified and genomic sequences, oligonucleotides, and PNA-oligomers that detect the cytosine methylation state of genomic DNA. It also presents a method for predicting a patient's response to endocrine treatment in breast tissue disorders, showcasing Schmitt's dedication to advancing cancer treatment through his work.

Career Highlights

Armin Schmitt has had an impactful career, contributing valuable innovations while working with influential companies. He has collaborated with Epigenomics AG and Metagen Pharmaceuticals GmbH, where his expertise in molecular biology and patentable inventions has been highly regarded.

Collaborations

Throughout his career, Schmitt has had the opportunity to work alongside distinguished colleagues such as John Foekens and Nadia Harbeck. Their collaborations have undoubtedly enriched research projects, leading to advancements in the understanding of cancer biology and treatment.

Conclusion

Armin Schmitt stands out as a prominent inventor in the realm of molecular biology, with his three patents fostering innovation in genetic sequencing and cancer therapy. His continued contributions will likely lead to further advancements in medical science, illustrating the crucial role that inventors like him play in shaping the future of healthcare.